Showing results (191-200 of 352) with videos related to
Sort By:
Pageof 36
Drugs & Aging|December 13, 2006
Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisationsMei Sheng Duh, Samir H Mody, R Scott McKenzie, et al.Current Medical Research and Opinion|January 28, 2021
Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitateDee Lin, Dominic Pilon, Maryia Zhdanava, et al.Future Oncology (London, England)|October 5, 2022
Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamideVincent M Bivins, Mike Durkin, Ibrahim Khilfeh, et al.Current Medical Research and Opinion|April 10, 2019
Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i)Stephen Brunton, Heather M Rozjabek, Dominic Pilon, et al.Current Medical Research and Opinion|August 24, 2021
Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims studyJeff Schein, Ann Childress, Julie Adams, et al.Journal of Cardiac Failure|March 30, 2018
Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial FibrillationJeffrey S Berger, Eric Peterson, François LalibertÉ, et al.Advances in Therapy|August 9, 2021
Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant DepressionMaryia Zhdanava, Swapna Karkare, Dominic Pilon, et al.Allergy and Asthma Proceedings|July 27, 2019
Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world studyAbhishek Kavati, Maryia Zhdanava, Benjamin Ortiz, et al.Journal of Medical Economics|October 29, 2014
Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic controlMarie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Gravel, et al.Journal of Medical Economics|January 24, 2022
Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspectiveJeff Schein, Lenard A Adler, Ann Childress, et al.Pageof 36